Enhance your practice with CME and tools that focus on the management of neurological conditions.
Starting With Confidence: A Practical Framework for Amyloid-Targeting Therapy in Early Alzheimer’s Disease
Dani Cabral, MD
Recognizing the Signs of TK2 Deficiency
Kaitlin Batley, MD
A Closer Look at the Biology Behind MS Progression
Ethan Meltzer, MD
Navigating Emerging Biomarkers in MS Care
Improving MS Diagnosis and Prognosis with Advanced Imaging and Biomarkers
Engineering Safer Antithrombotic Strategies for Secondary Stroke Prevention
C. Michael Gibson, MD, MS
Valeria Caso, MD, PhD
Ashkan Shoamanesh, MD
Navigating Emerging Treatment Options in MG
Qihua Fan, MD
Precision Medicine for Myasthenia Gravis
Shruti Raja, MD, MHS
Reimagining Alzheimer's Care: The Advent of Subcutaneous Administration of Anti-Amyloid Therapy
R. Scott Turner, MD, PhD
When “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic Alzheimer’s Disease
David Weisman, MD
Recurrence as the Rule: BD Symptoms Persist and Cycle
Jose M. Rubio, MD, PhD
Sunny X. Tang, MD
Navigating the Limitations of Current BD Therapies
The Role of B-Cell Depletion in MS Care
David Hafler, MD, FANA, MSc
Exploring Genetic Links Between EBV Clearance and MS Risk
The New Era of Targeted Therapy for Myasthenia Gravis
Immunologic Phenotyping: The Future of Personalized MG Care
Uncovering TK2d: How to Navigate Diagnostic Challenges
Implementing Cognitive Screening in MS Care
Elizabeth S. Gromisch, PhD
More Than a Myopathy: The Lived Experience of TK2d
Outcome Measures Capture Progression in Late-Onset TK2d
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.